JP2005523917A5 - - Google Patents

Download PDF

Info

Publication number
JP2005523917A5
JP2005523917A5 JP2003587762A JP2003587762A JP2005523917A5 JP 2005523917 A5 JP2005523917 A5 JP 2005523917A5 JP 2003587762 A JP2003587762 A JP 2003587762A JP 2003587762 A JP2003587762 A JP 2003587762A JP 2005523917 A5 JP2005523917 A5 JP 2005523917A5
Authority
JP
Japan
Prior art keywords
methyl
derivative according
present
butan
oxo groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003587762A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005523917A (ja
JP4315818B2 (ja
Filing date
Publication date
Priority claimed from IT2002MI000872A external-priority patent/ITMI20020872A1/it
Application filed filed Critical
Publication of JP2005523917A publication Critical patent/JP2005523917A/ja
Publication of JP2005523917A5 publication Critical patent/JP2005523917A5/ja
Application granted granted Critical
Publication of JP4315818B2 publication Critical patent/JP4315818B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003587762A 2002-04-23 2003-04-18 ハイパーフォリン誘導体、それらの使用及びそれらを含有している製剤 Expired - Fee Related JP4315818B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002MI000872A ITMI20020872A1 (it) 2002-04-23 2002-04-23 Derivati dell'iperforina loro uso e formulazioni che li contengono
PCT/EP2003/004100 WO2003091194A1 (en) 2002-04-23 2003-04-18 Hyperforin derivatives, the use thereof and formulations containing them

Publications (3)

Publication Number Publication Date
JP2005523917A JP2005523917A (ja) 2005-08-11
JP2005523917A5 true JP2005523917A5 (https=) 2006-06-15
JP4315818B2 JP4315818B2 (ja) 2009-08-19

Family

ID=11449767

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003587762A Expired - Fee Related JP4315818B2 (ja) 2002-04-23 2003-04-18 ハイパーフォリン誘導体、それらの使用及びそれらを含有している製剤

Country Status (18)

Country Link
US (2) USRE43280E1 (https=)
EP (1) EP1497250B1 (https=)
JP (1) JP4315818B2 (https=)
KR (1) KR100944052B1 (https=)
CN (1) CN1290816C (https=)
AT (1) ATE404519T1 (https=)
CA (1) CA2483205C (https=)
DE (1) DE60322871D1 (https=)
DK (1) DK1497250T3 (https=)
ES (1) ES2311697T3 (https=)
IL (1) IL164763A (https=)
IT (1) ITMI20020872A1 (https=)
NO (1) NO329176B1 (https=)
PL (1) PL205829B1 (https=)
PT (1) PT1497250E (https=)
RU (1) RU2320636C2 (https=)
SI (1) SI1497250T1 (https=)
WO (1) WO2003091194A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102772461B (zh) * 2011-05-11 2014-05-14 成都康弘药业集团股份有限公司 药物组合物在制备预防或治疗老年性痴呆的药物中的应用
US9321713B2 (en) * 2011-06-03 2016-04-26 President And Fellows Of Harvard College Hyperforin analogs, methods of synthesis, and uses thereof
ITMI20131012A1 (it) * 2013-06-19 2014-12-20 Indena Spa Derivati dell'iperforina e loro uso nella malattia di alzheimer
US20180071269A1 (en) 2015-08-12 2018-03-15 Tianxin Wang Therapeutical methods, formulations and nutraceutical formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2162520T3 (es) * 1998-02-13 2001-12-16 Schwabe Willmar Gmbh & Co Medicamentos basados en hiperforina y/o extractos de hiperforina.
AU743956B2 (en) 1998-02-13 2002-02-07 Dr. Willmar Schwabe Gmbh & Co Stable hyperforin salts, method for producing same and their use in the treatment of Alzheimer's disease
IT1301679B1 (it) * 1998-06-10 2000-07-07 Indena Spa Derivati dell'iperforina, loro uso e formulazioni che licontengono.

Similar Documents

Publication Publication Date Title
JP2012502037A5 (https=)
TWI316942B (en) Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
JP5345527B2 (ja) プロドラッグである5−アミノ−3−(3’−デオキシ−β−D−リボフラノシル)−チアゾロ[4,5−d]ピリミジン−2,7−ジオン
JP2023512666A (ja) N4-ヒドロキシシチジンおよび誘導体ならびにそれらに関連する抗ウイルス用途
JP2010504343A5 (https=)
MA30352B1 (fr) Pyridine [3,4-b] pyrazinones
JP2007145875A5 (https=)
TW200526237A (en) Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus
JP2009500423A5 (https=)
JP2006524660A5 (https=)
JP2007529532A5 (https=)
NO20090328L (no) Nye forbindelser 385
JP2009502743A5 (https=)
JP2007302689A5 (https=)
RU2008145714A (ru) Пуриновые производные в качестве активатора аденозинового рецептора
JP2003306481A5 (https=)
ATE386725T1 (de) Heterocyclylverbindungen
JP2019517990A5 (https=)
WO2008132552A3 (en) Omega-3 lipid compounds
HUP0402304A2 (hu) Deutériummal helyettesített dihidrofuranonszármazékok és azokat tartalmazó gyógyszerkészítmények
JP2008513510A5 (https=)
JP2009517411A5 (https=)
JP2004529172A5 (https=)
RU2003134629A (ru) Соединения цефема
JP2011508779A5 (https=)